Parabilis Medicines (formerly FogPharma)

Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for people living with cancer

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical

Model

01Company Overview

Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for people living with cancer. Through its Helicon discovery platform, Parabilis is engineering precisely tuned, stabilized helical peptide therapeutics that have the potential to unlock a large number of traditionally undruggable targets.

02Backed By1 investor

CCCatalio Capital Management→

03Recent Activity

Is this your company? Claim your profile

Startup Intelligence by F4F4 Research Engine

FROM Catalio Capital Management

Portfolio company Parabilis Medicines completed a record-setting $670M IPO on Nasdaq under ticker PBLS, the largest in the sector's history.

EXIT·x.com

JUN 11, 2026

04Similar Companies

P

Phoremost

Biotech & Life Sciences

→

PM

Parabilis Medicines

Biotech & Life Sciences

→

CT

Curve Therapeutics

Biotech & Life Sciences

→

LB

Lila Biologics

Biotech & Life Sciences

→

VT

Vividion Therapeutics

Biotech & Life Sciences

→

05Startup DNA

signals

Sectors
Business Model
Technology

Quick Reference

Sector

Biotech & Life Sciences · Healthcare & Digital Health